Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

A Randomized SAD and MAD Study Evaluating the Safety and Tolerability of RPh201 in Healthy Subjects and in Adults With Alzheimer's Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01513967
Recruitment Status : Completed
First Posted : January 20, 2012
Last Update Posted : December 6, 2016
Sponsor:
Collaborator:
Syneos Health
Information provided by (Responsible Party):
Regenera Pharma Ltd

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Completed
Actual Primary Completion Date : June 2015
Actual Study Completion Date : June 2015
Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 January 18, 2018
September 25, 2018
2 September 26, 2018
February 12, 2019
3 February 20, 2019
June 7, 2019